Durham, N.C. — Slate Pharmaceuticals, a startup focused on implantable hormones, has closed on nearly $5 million in funding, The News & Observer in Raleigh reported Wednesday.
Slate, which launched in 2007, also has an office in the United Kingdom.
The firm already markets Testopel, an implantable testosterone pellet.
Slate also is testing a menopausal hormone treatment.
Related Items
On The Web
Related Topics
- Health and Fitness
- Medical Specializations
- Medicine
- Menopause
- Obstetrics and Gynecology
- United Kingdom
- The News & Observer Publishing Company
- Raleigh
Related Stories Around the Web
- Risk of gall bladder disease with HRT patches lower than with HRT pills EurekAlert!, Jul. 10
- Aromatherapy Healthline, May. 31
- Red Clover Healthline, May. 29
- borage oil Healthline, May. 29
- Fight Breast Cancer at Every Meal Shape Magazine, Mar. 06
![[search]](http://wwwcache.wral.com/presentation/v1/images/icons/16x12/search-form-icon.gif)
Site Search
Report: Durham pharmaceutical startup raises some $5M
Copyright 2008 by WRAL.com. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
News Alerts to your Email & Cell Phone-
- U.S. tech industry added jobs in ’08 – before Wall Street crisis
Posted at 1:26 p.m. - German semiconductor maker to cut 190 jobs in Cary
Posted at 1:04 p.m. - N.C. Biofuels Center seeks president, two other executives
Posted at 12:43 p.m. - SciQuest expands reach in university e-procurement market
Updated at 2:23 p.m. - Broadway media firm uses Raleigh-based Inlet technology for iTunes shows
Posted at 10:56 a.m.
- U.S. tech industry added jobs in ’08 – before Wall Street crisis
-
- Despite the downturn, financing remains plentiful for cleantech
Posted at 7:25 a.m. - GSK business development exec to deliver SEBIO keynote
Oct. 14, 2008 - Cisco will back startup in smart grid space
Oct. 14, 2008 - Personal planner – with the DARPA touch
Oct. 14, 2008 - Fewer VC firms raise money in third quarter
Oct. 13, 2008
- Despite the downturn, financing remains plentiful for cleantech
More from wrallocaltechwire.com
Market Watch
